Developing Trustworthy Artificial Intelligence (AI)-Driven Tools to Predict Vascular Disease Risk and Progression

NCT06206369 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 11000

Last updated 2024-01-16

No results posted yet for this study

Summary

The VASCULAID-RETRO study, within the broader VASCULAID project, aims to create artificial intelligence (AI) algorithms that can predict cardiovascular events and the progression of abdominal aortic aneurysm (AAA) and peripheral arterial disease (PAD). The study plans to gather and analyze data from at least 5000 AAA and 6000 PAD patients, combining existing cohorts and retrospectively collected data. During this project, AI tools will be developed to perform automatic anatomical segmentation and analyses on multimodal imaging. AI prediction algorithms will be developed based on multisource data (imaging, medical history, -omics).

Conditions

  • Aneurysm Abdominal
  • Peripheral Arterial Disease

Interventions

OTHER

No intervention, retrospective study

No intervention, retrospective study

Sponsors & Collaborators

  • Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

    collaborator OTHER
  • Technical University of Twente

    collaborator OTHER
  • Universidade do Porto

    collaborator OTHER
  • Centre Hospitalier Universitaire de Nice

    collaborator OTHER
  • Stichting Allai

    collaborator UNKNOWN
  • Faculty of Medicine, University of Belgrade

    collaborator UNKNOWN
  • Brightfish Be

    collaborator UNKNOWN
  • Hospital District of Helsinki and Uusimaa

    collaborator OTHER
  • University of Bergen

    collaborator OTHER
  • Asklepios Kliniken Hamburg GmbH

    collaborator OTHER
  • University of Oxford

    collaborator OTHER
  • VINČA INSTITUTE OF NUCLEAR SCIENCES Belgrado

    collaborator UNKNOWN
  • Amsterdam UMC, location VUmc

    lead OTHER

Eligibility

Min Age
40 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-10-31
Primary Completion
2029-05-01
Completion
2029-05-01

Countries

  • Finland
  • Germany
  • Netherlands
  • Portugal
  • Serbia
  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06206369 on ClinicalTrials.gov